TC
DNA icon

TownSquare Capital’s Ginkgo Bioworks DNA Stock Holding History

TownSquare Capital’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-388
Closed -$28.1K – 1154
2023
Q3 		$28.1K Sell
388
-1,185
-75% -$94.7K ﹤0.01% 1088
2023
Q2 		$117K Buy
+1,573
New +$93.1K ﹤0.01% 1018

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TownSquare Capital's DNA Position: Q4 2023 in Review

TownSquare Capital sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 388 shares — an estimated $28.1K sold.

TownSquare Capital first reported a position in DNA in Q2 2023 and held it in 2 quarters. The position peaked at $117K in Q2 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

  • TownSquare Capital reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
  • TownSquare Capital sold 388 Ginkgo Bioworks shares in Q4 2023, an estimated $28.1K.
  • TownSquare Capital first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 2 quarters.
  • TownSquare Capital's Ginkgo Bioworks position peaked at $117K in Q2 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on TownSquare Capital's 13F filing for Q4 2023, filed 15 Feb 2024.